• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • Virtual Data Room (VDR) for Strategic Customized Slide Decks
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

NEW GENRE Audio English-Spanish – Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases, Reproductive Genomic Endocrinology – Volumes 1,2,3,4.

Series D: e-Books on BioMedicine – Metabolomics, Immunology, Infectious Diseases, Reproductive Genomic Endocrinology – NEW GENRE Audio English-Spanish – Volumes 1,2,3,4.

View on Amazon.com

Serie D:

Libros electrónicos de Biomedicina. Metabolómica, inmunología, enfermedades infecciosas, genómica reproductiva y endocr 

(4 book series) Kindle Edition

Series URL

https://www.amazon.com/dp/B0BR8P5TST

Volume Titles & URL on Amazon.com

Volumen 1

Genómica metabólica y farmacéutica (Serie D: Libros electrónicos de Biomedicina. Metabolómica, inmunología, enfermedades infecciosas, genómica reproductiva y endocr nº 1)

(Spanish Edition) Kindle Edition

http://www.amazon.com/dp/B0BR8DPPZW

Volumen 2

Enfermedades infecciosas y terapéutica (Serie D: Libros electrónicos de Biomedicina. Metabolómica, inmunología, enfermedades infecciosas, genómica reproductiva y endocr nº 2) (Spanish Edition)

(Spanish Edition) Kindle Edition

http://www.amazon.com/dp/B0BR8HPNK2

Volumen 3

El sistema inmunitario y la terapéutica (Serie D: Libros electrónicos de Biomedicina. Metabolómica, inmunología, enfermedades infecciosas, genómica reproductiva y endocr nº 3) (Spanish Edition)

(Spanish Edition) Kindle Edition

http://www.amazon.com/dp/B0BR8GYBG7

Volumen 4

Sistema reproductor humano, endocrinología genómica y tipos de cáncer (Serie D: Libros electrónicos de Biomedicina. Metabolómica, inmunología, enfermedades … y endocr nº 4) 

(Spanish Edition) Kindle Edition

https://www.amazon.com/dp/B0BRDH5M6T

Volume’s Date of Publication, Price, Audio

Spanish Series D

Date of Publication Spanish Edition Price

$268

English EditionPrice

$325

Audio

Volumen 1

12/28/2022 56 75

no

Volumen 2

12/28/2022 56 2&3

115

yes

Volumen

3

12/28/2022 56

no

 Volumen 4

12/29/2022 100 135

no

>>>

  • Original Volume One: Metabolic Genomics & Pharmaceutics

On Amazon.com since 7/21/2015

http://www.amazon.com/dp/B012BB0ZF0

  • NEW GENRE Volume One: Metabolic Genomics & Pharmaceutics

https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-d-e-books-on-biomedicine-metabolomics-immunology-infectious-diseases-reproductive-genomic-endocrinology/new-genre-volume-one-metabolic-genomics-pharmaceutics-series-d-volume-1%ef%bf%bc/

PART A: The eTOCs in Spanish in Audio format

PART B: The eTOCs in Bi-lingual format: Spanish and English in Text format

PART C: The Editorials of the original e-Books in English in Audio format

C.1: Editorials in English in Audio format

C.2: Editorials Supplemental in English in Text format

>>>

  • Original Volume Two & Three were published as ONE volume: 

On Amazon.com since September 4, 2017

https://www.amazon.com/dp/B075CXHY1B

The Immune System, Stress Signaling, Infectious Diseases and Therapeutic Implications

  • In the NEW GENRE E-SERIES these two volumes are published as two standalone books

>>>

  • Original Volume Two in the Volume Two and Three combined format: Infectious Diseases and Therapeutics
  • NEW GENRE Volume Two: Infectious Diseases and Therapeutics

https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-d-e-books-on-biomedicine-metabolomics-immunology-infectious-diseases-reproductive-genomic-endocrinology/new-genre-volume-two-infectious-diseases-and-therapeutics-series-d-volume-2-%ef%bf%bc/

PART A: The eTOCs in Spanish in Audio format

PART B: The eTOCs in Bi-lingual format: Spanish and English in Text format

PART C: The Editorials of the original e-Books in English in Audio format

>>>

  • Original Volume Three in the Volume Two and Three combined format: The Immune System and Therapeutics

On Amazon.com since September 4, 2017

https://www.amazon.com/dp/B075CXHY1B

  • NEW GENRE Volume Three:  The Immune System and Therapeutics

https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-d-e-books-on-biomedicine-metabolomics-immunology-infectious-diseases-reproductive-genomic-endocrinology/new-genre-volume-three-the-immune-system-and-therapeutics-pharmaceutics-series-d-volume-3-%ef%bf%bc/

PART A: The eTOCs in Spanish in Audio format

PART B: The eTOCs in Bi-lingual format: Spanish and English in Text format

PART C: The Editorials of the original e-Books in English in Audio format

>>>

  • Original Volume Four: Human Reproductive System, Genomic Endocrinology and Cancer Types

On Amazon.com  since February 2, 2021

http://www.amazon.com/dp/B08VTFWVKM

  • NEW GENRE Volume Four: Human Reproductive System, Genomic Endocrinology and Cancer Types

https://pharmaceuticalintelligence.com/audio-english-spanish-biomed-e-series/new-genre-audio-english-spanish-series-d-e-books-on-biomedicine-metabolomics-immunology-infectious-diseases-reproductive-genomic-endocrinology/new-genre-volume-four-human-reproductive-system-genomic-endocrinology-and-cancer-types-pharmaceutics-series-d-volume-4-%ef%bf%bc/

PART A: The eTOCs in Spanish in Audio format

PART B: The eTOCs in Bi-lingual format: Spanish and English in Text format

PART C: The Editorials of the original e-Books in English in Audio format

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading…

This page has the following sub pages.

  • NEW GENRE Volume One: Metabolic Genomics & Pharmaceutics – Series D, Volume 1
  • NEW GENRE Volume Two: Infectious Diseases and Therapeutics – Series D, Volume 2 
  • NEW GENRE Volume Three:  The Immune System and Therapeutics Pharmaceutics – Series D, Volume 3 
  • NEW GENRE Volume Four: Human Reproductive System, Genomic Endocrinology and Cancer Types Pharmaceutics – Series D, Volume 4 

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,037 other subscribers
  • Recent Posts

    • Novartis and Bristol Myers Squibb halt CAR-T trial for autoimmune diseases over patient deaths: a potential issue with cell-based manufacturing September 15, 2026
    • FDA Contemplates Changes in Trial Design, Drug Development, and Use of AI in Clinical Trials September 15, 2026
    • FDA Moves Forward With Its Guidance Framework for Rare Disease Trials: 2026 August 3, 2026
    • Artificial Intelligence TRANSFORMS Medicine, Biotech and Healthcare, How? August 3, 2026
    • In Memoriam: Nobel Laureate J. Michael Bishop for discovery of Retroviral Oncogenes July 31, 2026
    • Companies Actively Engaging Artificial Intellegence for Drug Design: 2026 July 31, 2026
    • AI-Native Drug Discovery Landscape 2026 – How LPBI Group Differentiates in the New Era of Foundation Models July 19, 2026
    • In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
    • Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
    • 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


Loading Comments...
%d